aluates Reports

$ 0.0

Automative

Global Respiratory Antivirals Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-33D1895

Global Respiratory Antivirals Market Insights Forecast to 2028

BUY CHAPTERS

Global Respiratory Antivirals Market Research Report 2025

Code: QYRE-Auto-33D1895

Report

June 2025

Pages:84

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GSK

Boehringer Ingelheim

Astrazeneca plc

Merck

Novartis

Beximco Pharmaceuticals

Pfizer Inc

Roche

Bristol Myers Squibb Company

Johnson & Johnson

AbbVie

Sanofi

Respiratory Antivirals Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Respiratory Antivirals Market

The global market for Respiratory Antivirals was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Respiratory Antivirals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Respiratory Antivirals.

The Respiratory Antivirals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Respiratory Antivirals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Respiratory Antivirals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Respiratory Antivirals Market Report

Report Metric	Details
Report Name	Respiratory Antivirals Market
CAGR	5%
Segment by Type	Nucleoside Analogs Neuraminidase Inhibitors Ion Channel Blockers Fusion Protein Inhibitors
Segment by Application	Upper Respiratory Tract Infections (URTIs) Influenza Bronchiolitis Pneumonia Measles Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Boehringer Ingelheim, AstraZeneca, Merck, Novartis, Beximco Pharmaceuticals, Pfizer, Roche, Bristol-Myers Squibb Company, Johnson & Johnson, AbbVie Inc., Sanofi
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Respiratory Antivirals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Respiratory Antivirals Market report?

Ans: The main players in the Respiratory Antivirals Market are GSK, Boehringer Ingelheim, AstraZeneca, Merck, Novartis, Beximco Pharmaceuticals, Pfizer, Roche, Bristol-Myers Squibb Company, Johnson & Johnson, AbbVie Inc., Sanofi

What are the Application segmentation covered in the Respiratory Antivirals Market report?

Ans: The Applications covered in the Respiratory Antivirals Market report are Upper Respiratory Tract Infections (URTIs), Influenza, Bronchiolitis, Pneumonia, Measles, Others

What are the Type segmentation covered in the Respiratory Antivirals Market report?

Ans: The Types covered in the Respiratory Antivirals Market report are Nucleoside Analogs, Neuraminidase Inhibitors, Ion Channel Blockers, Fusion Protein Inhibitors

Recommended Reports

Respiratory Therapeutics

Antiviral Drugs Market

Virus Diagnostics & Vaccines

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Respiratory Antivirals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nucleoside Analogs

1.2.3 Neuraminidase Inhibitors

1.2.4 Ion Channel Blockers

1.2.5 Fusion Protein Inhibitors

1.3 Market by Application

1.3.1 Global Respiratory Antivirals Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Upper Respiratory Tract Infections (URTIs)

1.3.3 Influenza

1.3.4 Bronchiolitis

1.3.5 Pneumonia

1.3.6 Measles

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Respiratory Antivirals Market Perspective (2020-2031)

2.2 Global Respiratory Antivirals Growth Trends by Region

2.2.1 Global Respiratory Antivirals Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Respiratory Antivirals Historic Market Size by Region (2020-2025)

2.2.3 Respiratory Antivirals Forecasted Market Size by Region (2026-2031)

2.3 Respiratory Antivirals Market Dynamics

2.3.1 Respiratory Antivirals Industry Trends

2.3.2 Respiratory Antivirals Market Drivers

2.3.3 Respiratory Antivirals Market Challenges

2.3.4 Respiratory Antivirals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Respiratory Antivirals Players by Revenue

3.1.1 Global Top Respiratory Antivirals Players by Revenue (2020-2025)

3.1.2 Global Respiratory Antivirals Revenue Market Share by Players (2020-2025)

3.2 Global Respiratory Antivirals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Respiratory Antivirals Revenue

3.4 Global Respiratory Antivirals Market Concentration Ratio

3.4.1 Global Respiratory Antivirals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Respiratory Antivirals Revenue in 2024

3.5 Global Key Players of Respiratory Antivirals Head office and Area Served

3.6 Global Key Players of Respiratory Antivirals, Product and Application

3.7 Global Key Players of Respiratory Antivirals, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Respiratory Antivirals Breakdown Data by Type

4.1 Global Respiratory Antivirals Historic Market Size by Type (2020-2025)

4.2 Global Respiratory Antivirals Forecasted Market Size by Type (2026-2031)

5 Respiratory Antivirals Breakdown Data by Application

5.1 Global Respiratory Antivirals Historic Market Size by Application (2020-2025)

5.2 Global Respiratory Antivirals Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Respiratory Antivirals Market Size (2020-2031)

6.2 North America Respiratory Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Respiratory Antivirals Market Size by Country (2020-2025)

6.4 North America Respiratory Antivirals Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Respiratory Antivirals Market Size (2020-2031)

7.2 Europe Respiratory Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Respiratory Antivirals Market Size by Country (2020-2025)

7.4 Europe Respiratory Antivirals Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Respiratory Antivirals Market Size (2020-2031)

8.2 Asia-Pacific Respiratory Antivirals Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Respiratory Antivirals Market Size by Region (2020-2025)

8.4 Asia-Pacific Respiratory Antivirals Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Respiratory Antivirals Market Size (2020-2031)

9.2 Latin America Respiratory Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Respiratory Antivirals Market Size by Country (2020-2025)

9.4 Latin America Respiratory Antivirals Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Respiratory Antivirals Market Size (2020-2031)

10.2 Middle East & Africa Respiratory Antivirals Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Respiratory Antivirals Market Size by Country (2020-2025)

10.4 Middle East & Africa Respiratory Antivirals Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Respiratory Antivirals Introduction

11.1.4 GSK Revenue in Respiratory Antivirals Business (2020-2025)

11.1.5 GSK Recent Development

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Details

11.2.2 Boehringer Ingelheim Business Overview

11.2.3 Boehringer Ingelheim Respiratory Antivirals Introduction

11.2.4 Boehringer Ingelheim Revenue in Respiratory Antivirals Business (2020-2025)

11.2.5 Boehringer Ingelheim Recent Development

11.3 AstraZeneca

11.3.1 AstraZeneca Company Details

11.3.2 AstraZeneca Business Overview

11.3.3 AstraZeneca Respiratory Antivirals Introduction

11.3.4 AstraZeneca Revenue in Respiratory Antivirals Business (2020-2025)

11.3.5 AstraZeneca Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Respiratory Antivirals Introduction

11.4.4 Merck Revenue in Respiratory Antivirals Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Respiratory Antivirals Introduction

11.5.4 Novartis Revenue in Respiratory Antivirals Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Beximco Pharmaceuticals

11.6.1 Beximco Pharmaceuticals Company Details

11.6.2 Beximco Pharmaceuticals Business Overview

11.6.3 Beximco Pharmaceuticals Respiratory Antivirals Introduction

11.6.4 Beximco Pharmaceuticals Revenue in Respiratory Antivirals Business (2020-2025)

11.6.5 Beximco Pharmaceuticals Recent Development

11.7 Pfizer

11.7.1 Pfizer Company Details

11.7.2 Pfizer Business Overview

11.7.3 Pfizer Respiratory Antivirals Introduction

11.7.4 Pfizer Revenue in Respiratory Antivirals Business (2020-2025)

11.7.5 Pfizer Recent Development

11.8 Roche

11.8.1 Roche Company Details

11.8.2 Roche Business Overview

11.8.3 Roche Respiratory Antivirals Introduction

11.8.4 Roche Revenue in Respiratory Antivirals Business (2020-2025)

11.8.5 Roche Recent Development

11.9 Bristol-Myers Squibb Company

11.9.1 Bristol-Myers Squibb Company Company Details

11.9.2 Bristol-Myers Squibb Company Business Overview

11.9.3 Bristol-Myers Squibb Company Respiratory Antivirals Introduction

11.9.4 Bristol-Myers Squibb Company Revenue in Respiratory Antivirals Business (2020-2025)

11.9.5 Bristol-Myers Squibb Company Recent Development

11.10 Johnson & Johnson

11.10.1 Johnson & Johnson Company Details

11.10.2 Johnson & Johnson Business Overview

11.10.3 Johnson & Johnson Respiratory Antivirals Introduction

11.10.4 Johnson & Johnson Revenue in Respiratory Antivirals Business (2020-2025)

11.10.5 Johnson & Johnson Recent Development

11.11 AbbVie Inc.

11.11.1 AbbVie Inc. Company Details

11.11.2 AbbVie Inc. Business Overview

11.11.3 AbbVie Inc. Respiratory Antivirals Introduction

11.11.4 AbbVie Inc. Revenue in Respiratory Antivirals Business (2020-2025)

11.11.5 AbbVie Inc. Recent Development

11.12 Sanofi

11.12.1 Sanofi Company Details

11.12.2 Sanofi Business Overview

11.12.3 Sanofi Respiratory Antivirals Introduction

11.12.4 Sanofi Revenue in Respiratory Antivirals Business (2020-2025)

11.12.5 Sanofi Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

GSK

Boehringer Ingelheim

Astrazeneca plc

Merck

Novartis

Beximco Pharmaceuticals

Pfizer Inc

Roche

Bristol Myers Squibb Company

Johnson & Johnson

AbbVie

Sanofi

List of Tables

Table 1. Global Respiratory Antivirals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nucleoside Analogs

Table 3. Key Players of Neuraminidase Inhibitors

Table 4. Key Players of Ion Channel Blockers

Table 5. Key Players of Fusion Protein Inhibitors

Table 6. Global Respiratory Antivirals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Respiratory Antivirals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Respiratory Antivirals Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Respiratory Antivirals Market Share by Region (2020-2025)

Table 10. Global Respiratory Antivirals Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Respiratory Antivirals Market Share by Region (2026-2031)

Table 12. Respiratory Antivirals Market Trends

Table 13. Respiratory Antivirals Market Drivers

Table 14. Respiratory Antivirals Market Challenges

Table 15. Respiratory Antivirals Market Restraints

Table 16. Global Respiratory Antivirals Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Respiratory Antivirals Market Share by Players (2020-2025)

Table 18. Global Top Respiratory Antivirals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Antivirals as of 2024)

Table 19. Ranking of Global Top Respiratory Antivirals Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Respiratory Antivirals Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Respiratory Antivirals, Headquarters and Area Served

Table 22. Global Key Players of Respiratory Antivirals, Product and Application

Table 23. Global Key Players of Respiratory Antivirals, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Respiratory Antivirals Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Respiratory Antivirals Revenue Market Share by Type (2020-2025)

Table 27. Global Respiratory Antivirals Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Respiratory Antivirals Revenue Market Share by Type (2026-2031)

Table 29. Global Respiratory Antivirals Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Respiratory Antivirals Revenue Market Share by Application (2020-2025)

Table 31. Global Respiratory Antivirals Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Respiratory Antivirals Revenue Market Share by Application (2026-2031)

Table 33. North America Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Respiratory Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Respiratory Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Respiratory Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Respiratory Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Respiratory Antivirals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Respiratory Antivirals Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Respiratory Antivirals Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Respiratory Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Respiratory Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Respiratory Antivirals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Respiratory Antivirals Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Respiratory Antivirals Market Size by Country (2026-2031) & (US$ Million)

Table 48. GSK Company Details

Table 49. GSK Business Overview

Table 50. GSK Respiratory Antivirals Product

Table 51. GSK Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 52. GSK Recent Development

Table 53. Boehringer Ingelheim Company Details

Table 54. Boehringer Ingelheim Business Overview

Table 55. Boehringer Ingelheim Respiratory Antivirals Product

Table 56. Boehringer Ingelheim Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 57. Boehringer Ingelheim Recent Development

Table 58. AstraZeneca Company Details

Table 59. AstraZeneca Business Overview

Table 60. AstraZeneca Respiratory Antivirals Product

Table 61. AstraZeneca Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 62. AstraZeneca Recent Development

Table 63. Merck Company Details

Table 64. Merck Business Overview

Table 65. Merck Respiratory Antivirals Product

Table 66. Merck Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 67. Merck Recent Development

Table 68. Novartis Company Details

Table 69. Novartis Business Overview

Table 70. Novartis Respiratory Antivirals Product

Table 71. Novartis Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 72. Novartis Recent Development

Table 73. Beximco Pharmaceuticals Company Details

Table 74. Beximco Pharmaceuticals Business Overview

Table 75. Beximco Pharmaceuticals Respiratory Antivirals Product

Table 76. Beximco Pharmaceuticals Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 77. Beximco Pharmaceuticals Recent Development

Table 78. Pfizer Company Details

Table 79. Pfizer Business Overview

Table 80. Pfizer Respiratory Antivirals Product

Table 81. Pfizer Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 82. Pfizer Recent Development

Table 83. Roche Company Details

Table 84. Roche Business Overview

Table 85. Roche Respiratory Antivirals Product

Table 86. Roche Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 87. Roche Recent Development

Table 88. Bristol-Myers Squibb Company Company Details

Table 89. Bristol-Myers Squibb Company Business Overview

Table 90. Bristol-Myers Squibb Company Respiratory Antivirals Product

Table 91. Bristol-Myers Squibb Company Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 92. Bristol-Myers Squibb Company Recent Development

Table 93. Johnson & Johnson Company Details

Table 94. Johnson & Johnson Business Overview

Table 95. Johnson & Johnson Respiratory Antivirals Product

Table 96. Johnson & Johnson Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 97. Johnson & Johnson Recent Development

Table 98. AbbVie Inc. Company Details

Table 99. AbbVie Inc. Business Overview

Table 100. AbbVie Inc. Respiratory Antivirals Product

Table 101. AbbVie Inc. Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 102. AbbVie Inc. Recent Development

Table 103. Sanofi Company Details

Table 104. Sanofi Business Overview

Table 105. Sanofi Respiratory Antivirals Product

Table 106. Sanofi Revenue in Respiratory Antivirals Business (2020-2025) & (US$ Million)

Table 107. Sanofi Recent Development

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Respiratory Antivirals Picture

Figure 2. Global Respiratory Antivirals Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Respiratory Antivirals Market Share by Type: 2024 VS 2031

Figure 4. Nucleoside Analogs Features

Figure 5. Neuraminidase Inhibitors Features

Figure 6. Ion Channel Blockers Features

Figure 7. Fusion Protein Inhibitors Features

Figure 8. Global Respiratory Antivirals Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Respiratory Antivirals Market Share by Application: 2024 VS 2031

Figure 10. Upper Respiratory Tract Infections (URTIs) Case Studies

Figure 11. Influenza Case Studies

Figure 12. Bronchiolitis Case Studies

Figure 13. Pneumonia Case Studies

Figure 14. Measles Case Studies

Figure 15. Others Case Studies

Figure 16. Respiratory Antivirals Report Years Considered

Figure 17. Global Respiratory Antivirals Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Respiratory Antivirals Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Respiratory Antivirals Market Share by Region: 2024 VS 2031

Figure 20. Global Respiratory Antivirals Market Share by Players in 2024

Figure 21. Global Top Respiratory Antivirals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Antivirals as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Respiratory Antivirals Revenue in 2024

Figure 23. North America Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Respiratory Antivirals Market Share by Country (2020-2031)

Figure 25. United States Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Respiratory Antivirals Market Share by Country (2020-2031)

Figure 29. Germany Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Respiratory Antivirals Market Share by Region (2020-2031)

Figure 37. China Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Respiratory Antivirals Market Share by Country (2020-2031)

Figure 45. Mexico Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Respiratory Antivirals Market Share by Country (2020-2031)

Figure 49. Turkey Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Respiratory Antivirals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. GSK Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 53. Boehringer Ingelheim Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 55. Merck Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 56. Novartis Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 57. Beximco Pharmaceuticals Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 58. Pfizer Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 59. Roche Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 61. Johnson & Johnson Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 62. AbbVie Inc. Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 63. Sanofi Revenue Growth Rate in Respiratory Antivirals Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza Antiviral Drugs Market

Direct acting Antiviral Drugs Market

Anti influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Respiratory Disorders Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Viral Pneumonia Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Specific Antiviral Drugs for COVID 19 Market

Cold Sore Antiviral Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Infectious Respiratory Disease Diagnostics Market Research Report 2025

Influenza Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Respiratory Infection Diagnostic Market Research Report 2024

Global Oral Antiviral Medicine Market Research Report 2025

Respiratory Syncytial Virus Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Anti infectious Disease Drugs Market Research Report 2025

Global Rhinovirus Infections Drug Market Research Report 2024

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Swine Respiratory Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions